medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2018, Number 6

<< Back Next >>

Rev Mex Urol 2018; 78 (6)

Risk factors associated with developing urinary tract infections caused by superbugs

Chavolla-Canal AJ, González-Mercado MG

Language: Spanish
References: 15
Page: 425-433
PDF size: 241.69 Kb.


ABSTRACT

Background: The recent appearance of pandrug resistance due to superbugs has become relevant in patients with urinary tract infections. Some risk factors have been described, but there are few studies published on the topic.
AIM: To analyze the risk factors related to urinary tract infections due to superbugs in the Mexican population.
Material and Method: In a descriptive, retrospective study, the medical records of patients that had urine cultures within the time frame of January 2007 to June 2015 were analyzed. The study variables were: sex, age, place of treatment, related diseases, prior surgeries, service in charge of the patient, reason for hospitalization, transfusion, treatment, indwelling urinary catheter, control culture, and death. Descriptive statistics were used for the data analysis.
Results: Thirty-one patients with superbug urinary infections were registered in the study. The most frequently isolated microorganism was Pseudomonas aeruginosa, predominating in men and advanced-age patients. Diabetes and high blood pressure were the most prevalent diseases. A history of transfusions and urinary catheter placement were risk factors associated with infection and mortality. Cephalosporins were the most widely prescribed antibiotics and the general mortality rate was 38.7%.
Conclusion: More research is needed on this topic, given the worldwide impact of infections that are resistant to the majority of drugs on antibiotic panels. The present study provided valuable information on the risk factors associated with the devastating phenomenon of pandrug resistant infection caused by superbugs.


REFERENCES

  1. Solorzano A, et al. Evolution of the resistance to antibiotic of bacteria involved in urinary tract infections: A 7-year surveillance study. Am J Infect Control 2014;42:1033-8. DOI: 10.1016/j.ajic.2014.06.013

  2. Ankur-Tyagi V, et al. Isolation and antibacterial susceptibility testing of multi drug resistant Pseudomonas aeruginosa causing urinary tract infections. J Chem Pharm Res 2011;3(4):342-347.

  3. Informe Epidemiológico de la Secretaria de Salud, México 2014. Incidencia de infección de vías urinarias por grupos de edad. Estados Unidos Mexicanos 2014. Población General.

  4. Rodriguez-Noriega E, et al. La evolución de la resistencia bacteriana en México, 1973-2013. Biomédica 2014;34(Supl.1):181-90. DOI: http://dx.doi.org/10.7705/ biomedica.v34i0.2142.

  5. Shah DA, et al. Antibiotic resistance pattern of Pseudomonas aeruginosa isolated from urine samples of urinary tract infections patients in Karachi, Pakistan. Pak J Med Sci. 2015; 2:341-345. DOI: 10.12669/pjms.312.6839

  6. De Francesco MA, et al. Prevalence of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in an Italian hospital. J Infect Public Health 2013;6(3):179-185. DOI: 10.1016/j.jiph.2012.11.006

  7. Pereira SG, et al. Multidrug and extensive drug resistance in Pseudomonas aeruginosa clinical isolates from a Portuguese central hospital: 10-year survey. Microb drug Resist 2015;2:194-200. DOI: 10.1089/mdr.2014.0137

  8. OSSA-GIRALDO, Ana Claudia et al. Factores de riesgo para infección por Pseudomonas aeruginosa multi-resistente en un hospital de alta complejidad. Rev Chil Infectol 2014;31(4):393-399. http://dx.doi.org/10.4067/S0716- 10182014000400003.

  9. Cornejo-Juárez P, et al. Patrones de resistencia bacteriana en urocultivos en un hospital oncológico. Salud Pub Mex 2007;49(5):330-336.

  10. Bjerklund-Johansen TE, et al. Prevalence of hospital-acquired urinary tract infections in urology departments. Eur Urol 2007;51(4):1100-11. DOI: 10.1016/j.eururo.2006.08.012

  11. Grabe M, et al. Guidelines on Urological Infections. European Association of Urology 2015;9-35 [en línea]. Dirección URL: .

  12. McDougal W, et al. Campbell-Walsh Urology 13th edition. In: Ewein AJ, et al. Philadelphia: Saunders-Elsevier, 2012;257.

  13. Peña C, et al. Risk-factors for acquisition of extendedspectrum b-lactamase-producing Escherichia coli among hospitalised patients. Clin Microbiol Infect 2006;12:279-284. http://dx.doi.org/10.1111/j.1469-0691.2005.01358.x

  14. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentysecond information supplement. Wayne(PA): Clinical and Laboratory Standards Institute ; 2012. Publication M-100-S22.

  15. Chavolla A, et al. Prevalencia de bacterias aisladas con resistencia antibiótica extendida en los cultivos de orina durante 8 años en un hospital de segundo nivel en México. Rev Mex Urol 2016;76(4):213-217. DOI: http://dx.doi: 10.1016/j. uromx.2016.04.00




2020     |     www.medigraphic.com